Yukihiko Shirayama, Michio Takahashi, Yasunori Oda, Kouhei Yoshino, Kouhei Yoshino, Koichi Sato, Toshiyuki Okubo, Masaomi Iyo. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer’s disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine. Brain Imaging and Behavior. 2019. 13. 1. 75-86
Takahashi M, Oda Y, Sato K, Shirayama Y. Vascular risk factors and the relationships between cognitive impairment and hypoperfusion in late-onset Alzheimer's disease. Acta neuropsychiatrica. 2018. 30. 6. 1-9